HOME > BUSINESS
BUSINESS
- RWD Suggests Lower Serious Adverse Event Risks for Entyvio vs. Anti-TNFα Antibodies: Takeda
October 24, 2019
- Zolgensma’s Japan Launch Delayed into 2020 as Sakigake Review Drags On, MHLW Still Eager to Make Decision by Year-End
October 23, 2019
- Tecentriq plus Avastin Extend OS, PFS in 1st Line HCC
October 23, 2019
- In Shocking U-Turn, Biogen/Eisai Say to File Aducanumab in Early Next Year
October 23, 2019
- Parexel Looks to Set Itself Apart from Rivals through Consulting Services
October 23, 2019
- Sumitomo Dainippon Lifts Q2 Earnings Guidance on Solid Sales in Japan, US, China
October 23, 2019
- European Panel Snubs Daiichi Sankyo’s Quizartinib
October 21, 2019
- JAK Debuts Draw Near in Japan Atopic Dermatitis Market, 1st Likely to Get Listing Next Spring
October 21, 2019
- FDA OKs Xofluza for Flu Patients Carrying High Complication Risks
October 21, 2019
- Shionogi, Janssen, Alzheimer’s Drug Discovery Foundation Join Forces to Develop AD Biomarkers
October 21, 2019
- Kyowa Kirin Recalling Mitomycin over Unauthorized Manufacturing Method, Supply Won’t Resume until 2021
October 18, 2019
- US FDA Panel Backs Shionogi’s Novel Antibiotic
October 18, 2019
- Sumitomo Dainippon Drops Bid to Buy Cynata
October 18, 2019
- FDA Gives Priority Status to Daiichi Sankyo/AZ’s HER2-Tageting ADC
October 18, 2019
- Ranitidine Compensation Programs Draw Complaints from Pharmacists, Separate Billing Seen “Unrealistic”
October 17, 2019
- Xofluza Filed in Japan for Post-Exposure Prophylaxis
October 17, 2019
- Asahi Kasei Initiates Voluntary Recall of Nafamostat after Glass Fragment Found in Vial
October 17, 2019
- Takeda to Divest 30 OTC, Non-Core Assets to Swiss Firm
October 16, 2019
- Astellas to Sell 3 Asian Products to Daiichi Sankyo for 9.6 Billion Yen
October 16, 2019
- FDA OKs 1st Schizophrenia Patch Drug: Hisamitsu
October 16, 2019
ページ
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
